Abstract:Cortical cell loss is a core feature of Huntington's disease (HD), beginning many years before clinical motor diagnosis, during the premanifest stage. However, it is unclear how genetic topography relates to cortical cell loss. Here, we explore the biological processes and cell types underlying this relationship and validate these using cell-specific post-mortem data. Eighty premanifest participants on average 15 years from disease onset and 71 controls were included. Using volumetric and diffusion MRI we extracted HD-specific whole brain maps where lower grey matter volume and higher grey matter mean diffusivity, relative to controls, were used as proxies of cortical cell loss. These maps were combined with gene expression data from the Allen Human Brain Atlas (AHBA) to investigate the biological processes relating genetic topography and cortical cell loss. Cortical cell loss was positively correlated with the expression of developmental genes (i.e. higher expression correlated with greater atrophy and increased diffusivity) and negatively correlated with the expression of synaptic and metabolic genes that have been implicated in neurodegeneration. These findings were consistent for diffusion MRI and volumetric HD-specific brain maps. As wild-type huntingtin is known to play a role in neurodevelopment, we explored the association between wild-type huntingtin (HTT) expression and developmental gene expression across the AHBA. Co-expression network analyses in 134 human brains free of neurodegenerative disorders were also performed. HTT expression was correlated with the expression of genes involved in neurodevelopment while co-expression network analyses also revealed that HTT expression was associated with developmental biological processes. Expression weighted cell-type enrichment (EWCE) analyses were used to explore which specific cell types were associated with HD cortical cell loss and these associations were validated using cell specific single nucleus RNAseq (snRNAseq) data from post-mortem HD brains. The developmental transcriptomic profile of cortical cell loss in preHD was enriched in astrocytes and endothelial cells, while the neurodegenerative transcriptomic profile was enriched for neuronal and microglial cells. Astrocyte-specific genes differentially expressed in HD post-mortem brains relative to controls using snRNAseq were enriched in the developmental transcriptomic profile, while neuronal and microglial-specific genes were enriched in the neurodegenerative transcriptomic profile. Our findings suggest that cortical cell loss in preHD may arise from dual pathological processes, emerging as a consequence of neurodevelopmental changes, at the beginning of life, followed by neurodegeneration in adulthood, targeting areas with reduced expression of synaptic and metabolic genes. These events result in age-related cell death across multiple brain cell types.

Longitudinal imaging highlights preferential basal ganglia circuit atrophy in Huntington's disease

Linking White Matter and Deep Gray Matter Alterations in Premanifest Huntington Disease.

Genetic Load Determines Atrophy in Hand Cortico-Striatal Pathways in Presymptomatic Huntington's Disease

Striatal morphology and neurocognitive dysfunction in Huntington disease: The IMAGE-HD study

Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy

Mapping the Order and Pattern of Brain Structural MRI Changes Using Change‐point Analysis in Premanifest Huntington's Disease

Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration

Differential Changes in Functional Connectivity of Striatum-Prefrontal and Striatum-Motor Circuits in Premanifest Huntington’s Disease

Brain Atrophy and Reorganization of Structural Network in Parkinson's Disease with Hemiparkinsonism

Selective vulnerability of layer 5a corticostriatal neurons in Huntington’s disease

Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review

Altered Iron and Microstructure in Huntington's Disease Subcortical Nuclei: Insight From 7T MRI

Postmortem neuropathology in early Huntington disease

Long somatic DNA-repeat expansion drives neurodegeneration in Huntington disease

Resting-state Fmri Reveals Potential Neural Correlates of Impaired Cognition in Huntington's Disease.

Longitudinal spatial mapping of lipid metabolites reveals pre-symptomatic changes in the hippocampi of Huntington's disease transgenic mice

Aberrant Resting-State Brain Activity in Huntington's Disease: A Voxel-Based Meta-Analysis

Multi-omic analysis of Huntington's disease reveals a compensatory astrocyte state

Progressive Cognitive Deficit, Motor Impairment and Striatal Pathology in a Transgenic Huntington Disease Monkey Model from Infancy to Adulthood

Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease reveal shared and tissue-specific effects

Microglial proliferation and astrocytic protein alterations in the human Huntington's disease cortex